Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

3 Biotechnology Stocks With Promising Pipelines

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming. Therefore, it could be wise to invest in solid biotech stocks Amgen (AMGN), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD) for substantial returns. Read more.

StockNews.com · Nov 1, 2024

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

Demand for the popular weight loss and diabetes drugs has spiked dramatically in recent years

The Independent UK · Oct 31, 2024

Why Pfizer Stock Is Lower After a Beat-and-Raise Quarter

Pfizer stock is down Tuesday even after the drugmaker reported higher-than-expected Q3 earnings and raised its full-year outlook.

Kiplinger · Oct 29, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Cheap Mexican Drugs Forcing Canadian Cartels to Export Meth to Other Countries

Canadian manufacturers of methamphetamine are being pushed to begin selling their product in foreign markets after being unable to compete with cheaper product from Mexico circulating in their home market.

Latin Times · Oct 29, 2024

More than half of WA pharmacies choosing not to stock vapes, survey shows

Exclusive: Uncertainty over regulations and discomfort over stocking a product not evaluated by drugs regulator among reasons given

The Guardian - AU · Oct 25, 2024

AstraZeneca ‘said it could cut UK jobs’ if biodiversity drug levy is introduced

Biotech giant’s alleged comments come as world leaders at Cop16 discuss how to share benefits from genetic code discoveries fairly

The Guardian - UK · Oct 25, 2024

Missouri Seeks to Block Access to Abortion Pill Because It's Stopping Teens from Getting Pregnant

Fewer teenage pregnancies means a population loss for the states, as well as "diminishment of political representation and loss of federal funds."

Latin Times · Oct 24, 2024

Read news from The Economist, FT, and more,
with one subscription

3 Pharma Stocks to Watch as Gene Therapy Gains Momentum

The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and improve treatment options. Given this favorable trend, it could be wise to watch strong pharma stocks such as Vertex Pharmaceuticals (VRTX), Wave Life Sciences (WVE), and Poseida Therapeutics (PSTX). Read more.

StockNews.com · Oct 23, 2024

US series with ‘most agonising cliffhanger’ in years is finally returning

Fans have been waiting more than two years for show to return

The Independent UK · Oct 23, 2024

Sanofi confirms €16 billion sale of painkiller Doliprane to US investors

French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.

Radio France Internationale · Oct 21, 2024

France Bristles At Painkiller Maker's Sale To US Fund

French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US investment fund sparked a new political backlash, stoked by fears the deal marks a loss of sovereignty over key medications.

International Business Times · Oct 21, 2024

France warns US buyer of Sanofi division of penalties for shifting production abroad

Private equity firm CD&R revealed to be in exclusive talks to buy 50% stake in consumer healthcare arm Opella

The Guardian - UK · Oct 21, 2024

Sanofi Pursues Sale Of Painkiller After Political Controversy

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.

International Business Times · Oct 21, 2024

Britons most likely in Europe to turn to unregulated alternative therapies

UK consumers are most likely patients in Europe likely to seek health advice from social media, poll suggests

The Independent UK · Oct 18, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com · Oct 17, 2024

3 Small-Cap Biotech Stocks With Game-Changing Potential

The biotech industry offers a compelling investment opportunity due to its potential for disruptive innovations and high growth. Thus, investing in fundamentally strong small-cap stocks Esperion Therapeutics (ESPR), Innoviva, Inc. (INVA), and SIGA Technologies (SIGA) could be significantly rewarding. Read on….

International Business Times · Oct 16, 2024

Visionary Marc DeValera: A Story of a Miraculous Discovery Turning into a Respiratory Treatment Revolution

Passionate about returning Big Pharma's power to the people, Marc DeValera, founder of MLFD-MedTech Inc., developed 3 essential oils using a Mesh Nebulizer, an all-natural alternative to respiratory treatments.

Evening Standard · Oct 15, 2024

Best Cytoplan supplements for women in midlife

Research has found that 40 per cent of women over the age of 45 have a chronic health condition

The Guardian - UK · Oct 15, 2024

‘The UK is at the back of the race of turtles’: Sanofi’s boss on the need to develop new medicines

Paul Hudson, the Briton in charge of the French drug firm, is a big believer in the potential of AI to transform healthcare

Get all your
news in one place.

100's of premium titles.
One news app.

Radio France Internationale · Oct 15, 2024

France could block sale of 'best-selling' drug if production doesn't stay local

France’s Economy Minister has warned that the government could block the sale of a subsidiary of the French pharmaceutical company Sanofi to a US private equity firm if it cannot guarantee that its production of paracetamol, under the name Doliprane, remains in France.

International Business Times · Oct 14, 2024

Painkiller Sale Plan To US Gives France Major Headache

The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after an outcry against the project from politicians on all sides.

The Guardian - UK · Oct 14, 2024

There’s an elephant in the room at Keir Starmer’s big investment summit: Brexit

We need a salvage operation to fix the problems this created. Otherwise, how else will we attract global investment, asks Labour MP Stella Creasy

Kiplinger · Oct 11, 2024

You Could Pay Only $2 for These Drugs Soon Under Medicare

Those enrolled in Medicare could soon pay just $2 for these prescription drugs.

The Guardian - US · Oct 11, 2024

Politicians’ proposals would only minimally lower US drug prices, says report

Advocates say multiple strategies must be used to lower prices as new drugs threaten to bankrupt health system

StockNews.com · Oct 9, 2024

3 Small-Cap Biotech Stocks to Buy for Major Upside

The biotech industry is flourishing with increasing investments and breakthrough developments. Thus, fundamentally solid small-cap biotech stocks BioCryst Pharmaceuticals (BCRX), Harmony Biosciences (HRMY), and Entrada Therapeutics (TRDA) with potential upside could be worth buying. Read more.

The Guardian - UK · Oct 9, 2024

GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac

British drugmaker agrees payment to resolve 80,000 cases alleging cancers were linked to drug known generically as ranitidine

1 … 33 34 35 36

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.